Lynn R. Shemanski
Lynn R. Shemanski publishes mostly in Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Pleural and Pulmonary Diseases.
- World rank
- #69,127 of 7,710,434 ranked researchers
- Rank in United States
- #26,685 of 1,627,098
- Works
- 51
- Citations
- 16k
- Citations per work
- 312.0
What does Lynn R. Shemanski research?
Lynn R. Shemanski's work is mostly in Medicine (64%), Mathematics (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3263.7%
- Medicine3263.7%
- Everything else1733.3%
- Physical Sciences23.0%
- Mathematics23.0%
- 1Pulmonary and Respiratory Medicine27% of their works
- 2Cardiology and Cardiovascular Medicine15% of their works
- 3Oncology10% of their works
- 4Surgery8% of their works
- 5Epidemiology4% of their works
- 6Statistics and Probability3% of their works
Research topics
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Occupational and environmental lung diseases
- Atrial Fibrillation Management and Outcomes
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- Cardiovascular Health and Disease Prevention
Which keywords describe Lynn R. Shemanski's research?
The keywords of their largest research topics: Chemotherapy, Immunotherapy, Clinical Trials, Targeted Therapy, ALK Inhibitors, CT Screening, EGFR Mutations and Lung Cancer.
- Endothelial Dysfunction
- Surgical Complications
- Pancreatic Cancer
- Atrial Fibrillation
- Pleural Effusion
- Empyema
- Lung Cancer
- CT Screening
- Targeted Therapy
- Immunotherapy
- Chemotherapy
- Clinical Trials
- ALK Inhibitors
- EGFR Mutations
- BAP1 mutations
- Malignant Pleural Mesothelioma
- Anticoagulant Therapy
- Genomic Profiles
- Small-Cell Lung Cancer
- Arterial Stiffness
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy173 topics
- Immunotherapy143 topics
- Clinical Trials132 topics
- Targeted Therapy132 topics
- ALK Inhibitors91 topic
- CT Screening91 topic
- EGFR Mutations91 topic
- Lung Cancer91 topic
- BAP1 mutations61 topic
- Empyema61 topic
- Malignant Pleural Mesothelioma61 topic
- Pleural Effusion61 topic
- Anticoagulant Therapy51 topic
- Atrial Fibrillation51 topic
- Genomic Profiles41 topic
- Pancreatic Cancer41 topic
- Small-Cell Lung Cancer41 topic
- Surgical Complications41 topic
- Arterial Stiffness31 topic
- Endothelial Dysfunction31 topic
Where does Lynn R. Shemanski work?
Lynn R. Shemanski's main affiliation in the publication record is Cancer Research And Biostatistics, United States.
How many publications and citations does Lynn R. Shemanski have?
OpenAlex counts 51 works and 15,910 citations for Lynn R. Shemanski, an h-index of 40, ranking #69,127 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lynn R. Shemanski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.